Steven Meehan is a seasoned professional with over 25 years of expertise in financial and operational leadership, excelling in corporate strategy, mergers and acquisitions, capital raising, and financial planning and analysis. His extensive background demonstrates a strong focus on navigating organizations through complex financial and strategic challenges, with a keen emphasis on value creation and growth acceleration.

Ya-El Mandel, PhD, MSc, is a distinguished leader in biopharmaceuticals and medical innovation. As a founding member and Senior Vice President of Clinical Operations at Équilibre Biopharmaceuticals Corp., and the founder and CEO of Cardea Sciences, she spearheads advancements in non-invasive platforms for Atrial Fibrillation risk assessment. A PhD alumna of the Icahn School of Medicine at Mount Sinai, she also contributes as an adjunct professor. With over a decade of expertise in clinical trials and emergency medical leadership, Dr. Mandel’s work seamlessly integrates academia, industry, and healthcare innovation, driving transformative progress in the field.